Kyle Rose
Stock Analyst at Canaccord Genuity
(3.14)
# 513
Out of 4,479 analysts
67
Total ratings
43.24%
Success rate
1.24%
Average return
Main Sectors:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PODD Insulet | Maintains: Buy | $226 → $234 | $196.16 | +19.29% | 5 | May 10, 2024 | |
| SYK Stryker | Upgrades: Buy | $360 | $336.50 | +6.98% | 10 | Jan 31, 2024 | |
| GMED Globus Medical | Maintains: Buy | $67 → $71 | $67.92 | +4.53% | 5 | Dec 20, 2023 | |
| ENOV Enovis | Maintains: Buy | $65 → $71 | $44.35 | +60.09% | 3 | Dec 20, 2023 | |
| INMD InMode | Downgrades: Hold | $55 → $22 | $17.87 | +23.11% | 7 | Oct 13, 2023 | |
| SKIN The Beauty Health Company | Assumes: Buy | $10 | $1.84 | +443.48% | 4 | Aug 25, 2023 | |
| ATEC Alphatec Holdings | Maintains: Buy | $17 → $22 | $9.98 | +120.44% | 1 | Aug 4, 2023 | |
| DXCM DexCom | Maintains: Buy | $135 → $150 | $112.17 | +33.73% | 9 | Jul 28, 2023 | |
| RBOT Vicarious Surgical | Maintains: Buy | $360 → $270 | $5.40 | +4,900.00% | 3 | May 31, 2023 | |
| SIBN SI-BONE | Maintains: Buy | $24 → $27 | $12.90 | +109.30% | 2 | May 2, 2023 | |
| TELA TELA Bio | Reiterates: Buy | $15 | $4.49 | +234.08% | 1 | Mar 28, 2023 | |
| AXGN AxoGen | Reiterates: Buy | $15 | $7.71 | +94.55% | 3 | Mar 28, 2023 | |
| ICE Intercontinental Exchange | Maintains: Market Perform | $125 → $122 | $136.93 | -10.90% | 1 | Mar 1, 2023 | |
| KRMD KORU Medical Systems | Upgrades: Buy | $3 → $4 | $2.35 | +70.21% | 3 | Nov 10, 2022 | |
| BVS Bioventus | Downgrades: Hold | n/a | $5.73 | - | 2 | Nov 9, 2022 | |
| FNA Paragon 28 | Maintains: Buy | $25 → $23 | $6.58 | +249.54% | 2 | Mar 9, 2022 | |
| ZBH Zimmer Biomet Holdings | Downgrades: Hold | $165 → $125 | $105.96 | +17.97% | 4 | Feb 8, 2022 | |
| SNN Smith & Nephew | Maintains: Buy | n/a | $24.51 | - | 2 | Apr 30, 2021 |
Insulet
May 10, 2024
Maintains: Buy
Price Target: $226 → $234
Current: $196.16
Upside: +19.29%
Stryker
Jan 31, 2024
Upgrades: Buy
Price Target: $360
Current: $336.50
Upside: +6.98%
Globus Medical
Dec 20, 2023
Maintains: Buy
Price Target: $67 → $71
Current: $67.92
Upside: +4.53%
Enovis
Dec 20, 2023
Maintains: Buy
Price Target: $65 → $71
Current: $44.35
Upside: +60.09%
InMode
Oct 13, 2023
Downgrades: Hold
Price Target: $55 → $22
Current: $17.87
Upside: +23.11%
The Beauty Health Company
Aug 25, 2023
Assumes: Buy
Price Target: $10
Current: $1.84
Upside: +443.48%
Alphatec Holdings
Aug 4, 2023
Maintains: Buy
Price Target: $17 → $22
Current: $9.98
Upside: +120.44%
DexCom
Jul 28, 2023
Maintains: Buy
Price Target: $135 → $150
Current: $112.17
Upside: +33.73%
Vicarious Surgical
May 31, 2023
Maintains: Buy
Price Target: $360 → $270
Current: $5.40
Upside: +4,900.00%
SI-BONE
May 2, 2023
Maintains: Buy
Price Target: $24 → $27
Current: $12.90
Upside: +109.30%
TELA Bio
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $4.49
Upside: +234.08%
AxoGen
Mar 28, 2023
Reiterates: Buy
Price Target: $15
Current: $7.71
Upside: +94.55%
Intercontinental Exchange
Mar 1, 2023
Maintains: Market Perform
Price Target: $125 → $122
Current: $136.93
Upside: -10.90%
KORU Medical Systems
Nov 10, 2022
Upgrades: Buy
Price Target: $3 → $4
Current: $2.35
Upside: +70.21%
Bioventus
Nov 9, 2022
Downgrades: Hold
Price Target: n/a
Current: $5.73
Upside: -
Paragon 28
Mar 9, 2022
Maintains: Buy
Price Target: $25 → $23
Current: $6.58
Upside: +249.54%
Zimmer Biomet Holdings
Feb 8, 2022
Downgrades: Hold
Price Target: $165 → $125
Current: $105.96
Upside: +17.97%
Smith & Nephew
Apr 30, 2021
Maintains: Buy
Price Target: n/a
Current: $24.51
Upside: -